HNB
BSX icon

Huntington National Bank’s Boston Scientific BSX Stock Holding History

Huntington National Bank’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$88.2M Sell
1,405,328
-22,806
-2% -$1.82M 0.49% 60
2025
Q4 		$136M Buy
1,428,134
+8,103
+0.6% +$794K 0.82% 29
2025
Q3 		$139M Buy
1,420,031
+31,750
+2% +$3.29M 0.85% 28
2025
Q2 		$149M Buy
1,388,281
+38,069
+3% +$3.85M 0.98% 25
2025
Q1 		$136M Buy
1,350,212
+89,515
+7% +$9.01M 0.99% 26
2024
Q4 		$113M Buy
1,260,697
+62,141
+5% +$5.47M 0.8% 27
2024
Q3 		$100M Buy
1,198,556
+84,830
+8% +$6.69M 0.73% 33
2024
Q2 		$85.8M Buy
1,113,726
+82,416
+8% +$6.03M 0.66% 37
2024
Q1 		$70.6M Buy
1,031,310
+97,600
+10% +$6.28M 0.57% 51
2023
Q4 		$54M Buy
933,710
+141,514
+18% +$7.55M 0.49% 58
2023
Q3 		$41.8M Buy
792,196
+151,507
+24% +$7.95M 0.42% 66
2023
Q2 		$34.7M Buy
640,689
+631,413
+6,807% +$33M 0.32% 88
2023
Q1 		$464K Buy
9,276
+1,069
+13% +$50.4K ﹤0.01% 478
2022
Q4 		$380K Sell
8,207
-873
-10% -$37.8K ﹤0.01% 511
2022
Q3 		$352K Sell
9,080
-1,262
-12% -$50.6K ﹤0.01% 508
2022
Q2 		$386K Buy
10,342
+1,278
+14% +$52K ﹤0.01% 506
2022
Q1 		$402K Buy
9,064
+1,075
+13% +$46.6K ﹤0.01% 525
2021
Q4 		$339K Buy
7,989
+518
+7% +$21.8K ﹤0.01% 547
2021
Q3 		$324K Sell
7,471
-766
-9% -$33.9K ﹤0.01% 531
2021
Q2 		$353K Sell
8,237
-44
-0.5% -$1.85K ﹤0.01% 524
2021
Q1 		$320K Sell
8,281
-2,298
-22% -$87K ﹤0.01% 453
2020
Q4 		$380K Sell
10,579
-667
-6% -$24K 0.01% 414
2020
Q3 		$430K Sell
11,246
-653
-5% -$25.2K 0.01% 387
2020
Q2 		$418K Buy
11,899
+461
+4% +$16.6K 0.01% 393
2020
Q1 		$374K Sell
11,438
-3,274
-22% -$128K 0.01% 397
2019
Q4 		$665K Buy
14,712
+2,569
+21% +$107K 0.01% 362
2019
Q3 		$494K Sell
12,143
-625
-5% -$26.5K 0.01% 387
2019
Q2 		$550K Sell
12,768
-2,471
-16% -$95K 0.01% 378
2019
Q1 		$585K Sell
15,239
-342
-2% -$13.1K 0.01% 369
2018
Q4 		$551K Sell
15,581
-2,725
-15% -$98.8K 0.01% 387
2018
Q3 		$705K Sell
18,306
-1,946
-10% -$68K 0.01% 384
2018
Q2 		$662K Sell
20,252
-7,105
-26% -$214K 0.01% 386
2018
Q1 		$747K Sell
27,357
-27,430
-50% -$746K 0.01% 378
2017
Q4 		$1.36M Sell
54,787
-5,925
-10% -$163K 0.02% 321
2017
Q3 		$1.77M Buy
60,712
+18,912
+45% +$522K 0.03% 294
2017
Q2 		$1.16M Buy
41,800
+40,613
+3,421% +$1.08M 0.02% 339
2017
Q1 		$30K Buy
1,187
+226
+24% +$5.5K ﹤0.01% 1005
2016
Q4 		$21K Hold
961
– – ﹤0.01% 1108
2016
Q3 		$23K Buy
961
+12
+1% +$286 ﹤0.01% 1100
2016
Q2 		$22K Buy
949
+43
+5% +$930 ﹤0.01% 1094
2016
Q1 		$16K Sell
906
-691
-43% -$12.1K ﹤0.01% 1396
2015
Q4 		$29K Hold
1,597
– – ﹤0.01% 1130
2015
Q3 		$26K Buy
1,597
+691
+76% +$11.8K ﹤0.01% 1191
2015
Q2 		$16K Hold
906
– – ﹤0.01% 1410
2015
Q1 		$16K Sell
906
-609
-40% -$9.63K ﹤0.01% 1403
2014
Q4 		$20K Buy
+1,515
New +$19.4K ﹤0.01% 1349
2014
Q1 		– Sell
-2,703
Closed -$32K – 1211
2013
Q4 		$32K Hold
2,703
– – ﹤0.01% 1220
2013
Q3 		$32K Buy
2,703
+1,188
+78% +$12.8K ﹤0.01% 1191
2013
Q2 		$14K Buy
+1,515
New +$12.9K ﹤0.01% 1364

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Huntington National Bank's BSX Position: Q1 2026 in Review

Huntington National Bank reduced its Boston Scientific (BSX) stake by 1.6% in Q1 2026, selling an estimated $1.82M and leaving 1,405,328 shares worth $88.2M. The position accounts for 0.49% of the portfolio, ranked #60.

Huntington National Bank first reported a position in BSX in Q2 2013 and has held it in 49 quarters since. The position peaked at $149M in Q2 2025. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Huntington National Bank held 1,405,328 shares of Boston Scientific worth $88.2M as of Q1 2026.
  • Huntington National Bank sold 22,806 Boston Scientific shares in Q1 2026, an estimated $1.82M.
  • Boston Scientific made up 0.49% of Huntington National Bank's portfolio in Q1 2026, its #60 holding.
  • Huntington National Bank first reported a position in Boston Scientific in Q2 2013 and has held it in 49 quarters since.
  • Huntington National Bank's Boston Scientific position peaked at $149M in Q2 2025.
  • 1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.